Résultats de recherche

...

...

In 2023 Ipsen launched its third global patient organization engagement survey, featuring the perspectives of 85 patient organizations (POs) globally. These findings will be used to help Ipsen deliver on what matters most to patients and caregivers. For th...

At Ipsen, improving patients’ lives drives us. We work together with patients, for patients. However, we know that understanding how to be more patient centric can be challenging, especially if you don’t work with patients in your day-to-day role. To h...

Résultats 2023 de l'enquête de satisfaction sur l'engagement des associations de patients d'Ipsen  ...

Chez Ipsen, l'amélioration de la vie des patients nous motive. Nous travaillons avec les patients, pour les patients. Cependant, nous savons qu'il peut être difficile de comprendre comment être plus centré sur le patient, en particulier si vous ne trav...

In the pharmaceutical industry, it’s easy to focus on data, strategy, and performance metrics. But behind every decision are real people. For Guillermo Castillo Acero, Head of European Mid-Sized Markets at Ipsen, that reality became clear during a pre...

New in our A Life in Science series, we hear from Mary Jane Hinrichs, Senior Vice President and Head of Early Development, about her path from discovering a passion for pharmacology to leading drug candidates through first-in-human trials. She shares how...

“We need to make sure that it’s scalable, safe, and reproducible—so that every patient gets the same medicine every time.”  ...